Does Allopurinol Regress Left Ventricular Hypertrophy in End Stage Renal Disease (Joint with University of Glasgow)

Project Details

StatusFinished
Effective start/end date1/04/1331/07/16

Funding

  • British Heart Foundation (PG/12/72/29743): £293,744.00

Research Output

An open label dose finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients

Rutherford, E., Stewart, G., Houston, J. G., Jardine, A. G., Mark, P. B. & Struthers, A. D., 10 Oct 2017, In : Journal of Clinical Pharmacology. 57, 11, p. 1409-1414 6 p.

Research output: Contribution to journalArticle

Open Access
File
1 Citation (Scopus)
130 Downloads (Pure)

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping

Rutherford, E., A. Talle, M., Mangion, K., Bell, E., Rauhalammi, S., McComb, C., Radjenovic, A., Welsh, P., Woodward, R., Struthers, A., Jardine, A. G., Patel, R. K., Berry, C. & Mark, P. B., Oct 2016, In : Kidney International. 90, 4, p. 845-852 8 p.

Research output: Contribution to journalArticle

Open Access
File
  • 36 Citations (Scopus)
    117 Downloads (Pure)